Discovery of a novel antibiotic class targeting the lipopolysaccharide 1 transporter
Carbapenem-resistant Acinetobacter baumannii (CRAB) has emerged as a major global pathogen with limited treatment options. The data in this project supports the discovery and optimization of tethered macrocyclic peptide (MCP) antibiotics with potent antibacterial activity against CRAB.